Kevin C. O'Boyle's most recent trade in Carlsmed Inc was a trade of 17,333 Common Stock done . Disclosure was reported to the exchange on July 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Carlsmed Inc | Kevin C. O'Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 17,333 | 17,333 | - | 0 | Common Stock | |
| Nevro Corp | Kevin C. O'Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 19,169 | 43,396 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kevin C. O'Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 6,754 | 24,227 (0%) | 0% | 0 | Common Stock | |
| Sientra Inc | Kevin C. O'Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 103,306 | 220,978 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Kevin C. O'Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,155 | 17,473 (0%) | 0% | 0 | Common Stock | |
| Sientra Inc | Kevin C. O'Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 16,870 | 117,672 (0%) | 0% | 0 | Common Stock |